Clinical aspects of allograft rejection.
D000328:Adult; D000906:Antibodies / Q000032:analysis; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001803:Blood Transfusion; D001806:Blood Urea Nitrogen; D003404:Creatinine / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control; D006650:Histocompatibility Testing; D006801:Humans; D007104:Immune Adherence Reaction; D007668:Kidney / Q000098:blood supply / Q000166:cytology / Q000503:physiopathology; D016030:Kidney Transplantation; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D008775:Methylprednisolone / Q000031:analogs & derivatives / Q000627:therapeutic use; D009504:Neutrophils; D011241:Prednisone / Q000627:therapeutic use; D012039:Regional Blood Flow; D006435:Renal Dialysis; D014021:Tissue Preservation; D014184:Transplantation, Homologous
D000906:Antibodies; D000961:Antilymphocyte Serum; D003520:Cyclophosphamide; D003404:Creatinine; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone